Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.

Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.

Item
http://www.wikidata.org/entity/Q38978377
Tumor-targeting, pH-sensitive nanoparticles for docetaxel delivery to drug-resistant cancer cellsTumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.Pluronic(®) P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide.Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.αvβ3 integrin-targeted micellar mertansine prodrug effectively inhibits triple-negative breast cancer in vivo.
P2860

Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.

Item
http://www.wikidata.org/entity/Q38978377
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Antitumor activity of PEGylate ...... triple-negative breast cancer.
@en
type
label
Antitumor activity of PEGylate ...... triple-negative breast cancer.
@en
prefLabel
Antitumor activity of PEGylate ...... triple-negative breast cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Antitumor activity of PEGylate ...... triple-negative breast cancer.
@en
P2093
P304
P31
P356
10.1016/J.IJPHARM.2014.06.058
P407
P433
P478
P50
P577
P698
P921